Regulatory Updates
Sep 25, 2026•1 min read
FDA Approves ANDA 077179 for Amlodipine Besylate/Benazepril Hydrochloride Capsules (Discontinued)
The FDA’s ANDA 077179 approval covers oral capsule products of amlodipine besylate combined with benazepril hydrochloride, all listed as discontinued, with labeling submissions approved in 2011 and 2016.
Regulatory Updates
Sep 10, 2026•1 min read
FDA approves ANDA090609 for atomoxetine capsules by Dr. Reddy's Laboratories
FDA has granted approval for ANDA090609, allowing Dr. Reddy's Laboratories to market generic atomoxetine hydrochloride oral capsules in multiple strengths.